Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

    Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

    Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

    We pioneer breakthroughs in healthcare. For everyone. Everywhere. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

    1. Home

    2. Perspectives

    3. Insights from this year’s RSNA

    Insights from this year’s RSNA

    3min
    Published on November 27, 2017
    Nexaris Therapy Suites is just one solution Siemens Healthineers has unveiled at RSNA 2017 in Chicago.

    At the nexus of treatment innovation

    The new MAMMOMAT Revelation is one of siemens medical systems that was launched at this year’s RSNA.

    More comfort for breast screening patients

    CT solutions as individual as clinical needs

    At RSNA 2017 Siemens Healthineers is addressing the most frequent MRI examiniation, imaging the knee, with the GOKnee3D application.

    Addressing the most frequent MR examination

    Siemens Healthineers introduced the new Biograph Vision for PET/CT at RSNA 2017.

    Next generation of PET/CT

    At RSNA 2017 you will get insights about the Siemens Healthineers Digital Ecosystem which will allow you to tap into the potential of digitalization.

    Fast and easy access to actionable insights

    1. The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
    2. The product is pending 510(k) clearance, and is not yet commercially available in the U.S.
    3. Examination time for 3T system is 10 minutes, for a 1.5T system is up to 11 minutes. All given examination times are examination only, adjustments have been excluded.

    4. Biograph Vision and it's features and applications are currently under development; are not for sale in the U.S. or other countries worldwide.

      Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

    5. syngo.via can be used as a standalone device or together with a variety of syngo.via-based software options, which are medical devices in their own right. syngo.via and the syngo.via based software options are not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
    6. Digital Ecosystem is not commercially available in all countries. If the services are not marketed in countries due to regulatory or other reasons, the service offering cannot be guaranteed. Please contact your local Healthineers organization for further details.
    7. The statements by Siemens’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.